Home > Insider Trading > Filing (0001401708-21-000122)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1401708	Nanostring Technologies Inc	NSTG	Biological Products, (No Disgnostic Substances) (2836)	200094687

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1575739	Bradley R Gray	530 Fairview Avenue N Seattle WA 98109	President And Ceo	Yes	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2021-03-15	21,994	$0.00	205,483	No	4	M	Direct
Common Stock	Disposition	2021-03-16	8,817	$66.32	196,666	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Footnotes

Each restricted stock unit ("RSU") represents a contingent right to receive one (1) share of Issuer's common stock.
On March 17, 2021, the Reporting Person filed a Form 4 which inadvertently misstated the number of shares held by the Reporting Person following the vesting of 21,994 RSUs reported on the Form 4. The number of shares reported in Column 5 of this Form 4/A reflects the corrected amount of securities beneficially owned by the Reporting Person following the vesting of such RSUs on March 15, 2021.
The reported shares were sold to cover the reporting person's tax liability in connection with the vesting of RSUs.
On March 17, 2021, the Reporting Person filed a Form 4 which (i) included an incorrect Transaction Code in Column 3 of the Form 4 in relation to a sale of shares to cover the Reporting Person's tax liability in connection with the vesting of RSUs, (ii) in Column 4, inadvertently misstated the price at which the shares were sold, and (iii) in Column 5, inadvertently misstated the number of shares held by the Reporting Person following the sale of shares reported in the Form 4. The Transaction Code reported in Column 3 of this Form 4/A, the price reported in Column 4 of this Form 4/A and the number of shares reported in Column 5 of this Form 4/A reflect corrections to these items.